Q32 Bio (QTTB) Operating Margin Growth (1y) (2019 - 2023)
Q32 Bio (QTTB) Operating Margin Growth (1y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 619,872.00 |
| Sep 30, 2023 | 367,803.00 |
| Jun 30, 2023 | 330,256.00 |
| Mar 31, 2023 | 444,034.00 |
| Dec 31, 2022 | -10,835.00 |
| Sep 30, 2022 | -226,918.00 |
| Jun 30, 2022 | -213,257.00 |
| Mar 31, 2022 | -468,673.00 |
| Dec 31, 2021 | -115,162.00 |
| Sep 30, 2021 | 315,810.00 |
| Jun 30, 2021 | 489,879.00 |
| Mar 31, 2021 | 620,233.00 |
| Dec 31, 2020 | 149,877.00 |
| Sep 30, 2020 | 210,836.00 |
| Jun 30, 2020 | 84,020.00 |
| Mar 31, 2020 | 309,869.00 |
| Dec 31, 2019 | -285,316.00 |
| Sep 30, 2019 | -611,882.00 |
| Jun 30, 2019 | -617,382.00 |
| Mar 31, 2019 | -835,743.00 |